Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and reduces costs ...

"For me, it is a wake-up call for our country and for the African continent as a whole. We must not let the crisis pass (in ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations., Hea ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Speaking at a meeting of the Mizoram Legislative Forum on AIDS a high-level committee of ... specifically targeting CD4 cells (T cells), which help fight infections. If left untreated, HIV can ...

In HIV-positive MSM, pain severity was significantly associated with pain management experiences and unhealthy alcohol use.

An AI-enabled device could make flow cytometry affordable and accessible, reports a new study from Rice University.

Modern HIV treatment offers remarkable outcomes. This guide explores essential first steps, treatment advances, support ...

Long-Term Outcomes Reinforce the High Efficacy of Biktarvy ® in People with HIV and HBV Coinfection – – Investigational Long-Acting, Twice-Yearly Treatment Regimen of Len ...